Company Overview of SR One
SR One is the venture capital arm of GlaxoSmithKline specializing in investing in seed, start up, early and mid venture; and emerging growth companies. It seeks to invest in emerging life science companies that are pursuing innovative science which will significantly impact medical care, with products in preclinical development stage through clinical proof-of-concept; biotechnology; healthcare; medical devices, and related information technologies companies. It typically invests in companies based globally with a focus on the United States, Canada, and Europe. The firm typically invests between $500,000 and $5 million per round. It prefers to take a board seat or observers right in its portf...
161 Washington Street
Eight Tower Bridge
Conshohocken, PA 19428-2077
Founded in 1985
Key Executives for SR One
Compensation as of Fiscal Year 2015.
SR One Key Developments
SR One Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 through Sep-30-2015
Jul 31 15
SR One Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 through Sep-30-2015. Venue: Congress Center, Basel, Switzerland. Presentation Date & Speakers: Sep-29-2015, David Phillips, Partner, Deborah Harland, Partner.
SR One Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015 04:30 PM
Jun 22 15
SR One Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015 04:30 PM. Venue: The Digital Sandbox, 55 Broad Street 4th Floor, New York, NY 10004, United States. Speakers: Rajeev Dadoo, Partner.
SR One Presents at Bio-Trinity, May-11-2015 through May-13-2015
Apr 29 15
SR One Presents at Bio-Trinity, May-11-2015 through May-13-2015. Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom. Presentation Date & Speakers: May-12-2015, Deborah Harland, Partner. May-13-2015, David Phillips, Partner.
Similar Private Companies By Industry
Recent Private Companies Transactions